Open-Label Uridine for Treatment of Depressed Adolescents with Bipolar Disorder
This report is an open-label case series of seven depressed adolescents with bipolar disorder treated with uridine for 6 weeks. Treatment response was measured with the Children's Depression Rating Scale-Revised and the Clinical Global Impressions scale. Uridine was associated with decreased depressive symptoms, and was well tolerated by study participants. Further systematic studies of uridine are warranted.
Scientific Studies & Papers
Author of Study or Paper
Kondo DG1, Sung YH, Hellem TL, Delmastro KK, Jeong EK, Kim N, Shi X, Renshaw PF.
Source
The Brain Institute, University of Utah, Salt Lake City, Utah
Date Published
2011
Scientific Link
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080753/
{{#ratings}}
{{title}}
{{#ownerCreatedBlock}}
{{/ownerCreatedBlock}}
{{#category}}
{{#editor}}
{{/editor}}
{{#user}}
{{/user}}
{{/ratings}}
-
{{#owner}}
-
{{#url}}
{{#avatarSrc}}
{{name}} {{/url}} {{^url}} {{#avatar}} {{& avatar}} {{/avatar}} {{name}} {{/url}} - {{/owner}} {{#created}}
- {{created}} {{/created}}
Category: {{category.title}}
{{/category}}
{{#fields}}
{{#showLabel}}
{{/fields}}
{{label}}:
{{/showLabel}}
{{& text}}
